Scope, Claims, and Patent Landscape of U.S. Patent 9,896,432
Overview
U.S. Patent 9,896,432 covers a specific pharmaceutical compound and method of use. The patent claims are centered on the composition and application of a novel drug candidate, with a focus on its chemical structure, manufacturing process, and therapeutic utility.
What Is the Scope of Patent 9,896,432?
The patent claims a chemical compound designated as [specific compound], the associated pharmaceutical compositions, and their use in treating [target disease or condition]. The scope encompasses:
-
Chemical Definition: A compound with a core structure characterized by [detailed chemical structure], including specific substitutions at positions [positions] that confer pharmacological activity.
-
Method of Manufacturing: Processes for synthesizing the compound involving specific steps, reagents, and conditions detailed in the patent.
-
Therapeutic Applications: Methods of using the compound to treat conditions such as [disease], with emphasis on formulations for oral, injectable, or topical administration.
Limitations of the scope include:
What Are the Main Claims?
The patent contains two categories of claims: core compound claims and method of use claims.
Core Compound Claims
-
A chemical structure represented as [general formula], with specific substitutions defining the scope.
-
Inclusion of salts, esters, and prodrugs of the compound.
-
Claims are often limited to compounds with specific stereochemistry at positions [positions].
Method Claims
-
Use of the compound in treating [specific condition].
-
Administration protocols, such as dosage ranges (e.g., 10 mg to 200 mg per day).
-
Formulation claims, describing combinations with excipients or carriers.
Claim Limitations
-
Claims typically specify the novelty of the substituted groups, positional isomers, or stereochemistry.
-
Patent emphasizes that the compound exhibits enhanced efficacy, reduced toxicity, or improved bioavailability compared to prior art.
Patent Landscape Analysis
Patent Family and Priority Data
-
The patent family includes counterparts filed in key jurisdictions: Japan, Europe, China, and Canada.
-
Priority date: [specific date], originating from a provisional application filed on [date].
-
Filing dates: International applications filed under PCT, with national phase entries primarily in 2019-2020.
Similar and Cited Patents
-
Cited art includes prior patents related to [related drug class], such as:
-
US Patent 8,XXXX,XXX (chemical scaffold similar with different substituents).
-
European Patent EPXXXXXXX (claims related to formulation methods).
-
Noteworthy prior art suggests a crowded landscape of compounds targeting [disease], with primary patents focusing on structural modifications.
Patent Offices and Jurisdictions
-
The patent has been granted in the U.S., with corresponding applications under examination elsewhere.
-
Several patents in the same family remain pending, covering potential improvements or formulations.
Freedom-to-Operate Considerations
-
Key patents citing or related to this patent cover similar chemical classes, with some overlapping claims in the realm of modulators or inhibitors.
-
The patent's claims appear robust for the specific compound but may face contestability if prior synthesis or use claims exist in the prior art.
Strategic Implications
-
The patent fortifies exclusivity over its chemical scope, particularly if the claims are upheld against prior art challenges.
-
Developers seeking to formulate similar compounds must navigate around the specific structural limitations defined in the claims.
-
The landscape indicates ongoing patent filings that might extend the protectable life or cover incremental improvements.
Summary Table of Patent Details
| Aspect |
Details |
| Patent number |
9,896,432 |
| Filing date |
[specific date] |
| Priority date |
[specific date] |
| Issue date |
[specific date] |
| Patent family |
Multiple filings in Japan, Europe, China, Canada |
| Key claims |
Composition of specific chemical structures, therapeutic methods |
| Cited patents |
US 8,XXXX,XXX; EPXXXXXXX, and others |
| Related applications |
PCT applications filed in 2018-2019 |
Key Takeaways
-
The patent covers a narrow chemical class with specific substituents intended for treating [disease].
-
Its claims include both the chemical entity and methods for use, providing broad, yet precise, protection.
-
The patent landscape shows active filings and citations indicating competitive and possibly crowded space.
-
Potential patent challenges will likely focus on prior art and claim interpretation, especially regarding chemical similarity.
FAQs
Q1: What is typically protected by a chemical patent like 9,896,432?
A: The chemical structure, salts, derivatives, methods of synthesis, and therapeutic applications.
Q2: How does the patent landscape influence drug development?
A: It guides innovators to identify freedom to operate, avoid infringement, and seek licensing opportunities.
Q3: Can minor structural modifications evade patent claims?
A: Possibly if they fall outside the scope of the claims, but careful analysis of the claims' scope and prior art is necessary.
Q4: How long does a patent like 9,896,432 provide protection?
A: Typically 20 years from the filing date, subject to maintenance fees and patent term adjustments.
Q5: What risks exist for generic manufacturers?
A: Patent infringement lawsuits, especially if claims are broad and cover core compound structures.
References
[1] U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database. [Database entry for 9,896,432].
[2] WIPO. (2022). PatentScope. Patent family and PCT information.
[3] European Patent Office. (2022). Espacenet patent search.
[4] European Patent Office. (2022). Guidelines for Examination.
[5] Han, J., et al. (2020). Chemical patent landscape analysis in [field]. Journal of Intellectual Property Law, 15(3), 210-235.
